Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-026944
Filing Date
2024-11-15
Accepted
2024-11-15 16:05:16
Documents
1
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 form4-11152024_091112.html 4  
1 form4-11152024_091112.xml 4 45119
  Complete submission text file 0001415889-24-026944.txt   46584
Mailing Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005 650-770-0077
Vera Therapeutics, Inc. (Issuer) CIK: 0001831828 (see all company filings)

EIN.: 812744449 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERA THERAPEUTICS, INC. 2000 SIERRA POINT PARKWAY, SUITE 1200 BRISBANE CA 94005
Business Address
Fordyce Marshall (Reporting) CIK: 0001859453 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40407 | Film No.: 241467804